Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Marcia Brose, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00654238
First received: April 1, 2008
Last updated: June 20, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)